How Much Does Amyotrophic lateral sclerosis Treatment Cost in Tianjin?
| China | Turkey | Austria | |
|---|---|---|---|
| Stem cell therapy for ALS (amyotrophic lateral sclerosis) | ≈ $22,000 | from $10,000 | ≈ $14,000 |
| Stem Cell Therapy | from $29,700 | from $900 | ≈ $8,500 |
| Plasmapheresis | ≈ $2,200 | from $3,200 | ≈ $1,500 |
| Induced Pluripotent Stem Cells Therapy | from $47,500 | ≈ $6,500 | ≈ $14,000 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Amyotrophic lateral sclerosis treatment and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Amyotrophic lateral sclerosis treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Amyotrophic lateral sclerosis treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Amyotrophic lateral sclerosis Hospitals in Tianjin: 1 Verified Option and Prices
Get a Medical Assessment for Amyotrophic lateral sclerosis in China: Consult with Experienced Doctors Now
View all Doctors
Shao Ming
Dr. Shao Ming is a leading neurologist with postdoctoral training at Harvard and the University of Texas, specializing in epilepsy and neurophysiological monitoring.
- Doctor of Medical Sciences with extensive clinical experience
- Introduced propofol for the Wada test in China, improving surgical safety
- Author of over 50 scientific articles, including 30 in international journals
- Featured in The Journal of Neuroscience for groundbreaking epilepsy research
- Multiple grant recipient for epilepsy research in the U.S. and China
Share this content
Anna Leonova

